Early research (Phase 1)Study completedNCT00002765What this trial is testingImmunotoxin in Treating Patients With Leukemia or LymphomaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT03936153What this trial is testingStudy to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma (DLBCL) Xynomic Pharmaceuticals, Inc. 170
Early research (Phase 1)Active Not RecruitingNCT04464200What this trial is testing19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell CancersWho this might be right forDiffuse Large B Cell LymphomaPrimary Mediastinal Large B Cell LymphomaTransformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma+6 more Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00003245What this trial is testingIrinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT05842707What this trial is testingStudy of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin LymphomaWho this might be right forRefractory or Relapsed B-cell Non-Hodgkin Lymphoma Aibin Liang，MD，Ph.D. 48
Not applicableUnknownNCT02813837What this trial is testingChimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic MalignanciesWho this might be right forLeukemia, B-CellLymphoma, B-Cell Innovative Cellular Therapeutics Co., Ltd. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04442022What this trial is testingRituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaWho this might be right forRelapsed/Refractory Diffuse Large B-cell Lymphoma Karyopharm Therapeutics Inc 501
Testing effectiveness (Phase 2)Looking for participantsNCT05702853What this trial is testingMetabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLLWho this might be right forB-cell Non Hodgkin LymphomaChronic Lymphocytic Leukemia Medical University of South Carolina 27
Testing effectiveness (Phase 2)WithdrawnNCT04607772What this trial is testingStudy of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forRelapsed or Refractory Diffuse Large B-Cell Lymphoma Karyopharm Therapeutics Inc
Early research (Phase 1)UnknownNCT05020639What this trial is testingTQB3820 in Patients With Hematological MalignanciesWho this might be right forHematological Malignancies Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 116
Testing effectiveness (Phase 2)Study completedNCT02342665What this trial is testingJapanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHLWho this might be right forLymphoma Non-Hodgkin Bayer 25
Testing effectiveness (Phase 2)Ended earlyNCT00383565What this trial is testingFR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma National Cancer Institute (NCI) 9
Early research (Phase 1)Active Not RecruitingNCT06079164What this trial is testingStudy of KITE-197 in Participants With Relapsed or Refractory Large B-cell LymphomaWho this might be right forRelapsed/Refractory Large B-cell Lymphoma Kite, A Gilead Company 21
Early research (Phase 1)Study completedNCT05233033What this trial is testingSafety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHLWho this might be right forNon Hodgkin LymphomaDiffuse Large B Cell LymphomaDLBCL+1 more Kymera Therapeutics, Inc. 7
Early research (Phase 1)Study completedNCT02175433What this trial is testingEvaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid MalignanciesWho this might be right forRelapsed Lymphoid MalignancyRefractory Lymphoid Malignancy Astellas Pharma Global Development, Inc. 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770698What this trial is testingSonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic LeukemiaWho this might be right forRelapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic Leukemia+9 more BeOne Medicines 30
Early research (Phase 1)Study completedNCT04313608What this trial is testingA Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell LymphomaWho this might be right forB-cell Lymphoma Hoffmann-La Roche 23
Early research (Phase 1)Study completedNCT01991184What this trial is testingGDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.Who this might be right forLymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma Genentech, Inc. 24
Very early researchStudy completedNCT04689204What this trial is testingCTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma He Huang 3
Testing effectiveness (Phase 2)Study completedNCT00059904What this trial is testingRituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center